Home >> Signaling Pathways >> Chromatin/Epigenetics >> JAK

JAK

Janus kinases (JAKs), belonging to a distinct family of tyrosine kinases, are non-receptor tyrosine kinases that transduce signals of cytokine receptors via diverse signal transduction pathways. Mammalian JAK family consists of four structurally similar members, JAK1, JAK2, JAK3 and Tyrosine kinase 2 (TYK2), which are characterized by containing seven JAK homology (JH) domains. The presence of JH1 and JH2 domains is the most intriguing feature of JAK proteins. JH1 domain is the main catalytic domain; while JH2 is usually considered as a catalytically inactive pseudokinase domain. However, results of recent studies have shown that JH2 acts as a dual-specificity protein kinase to phosphorylate two regulatory sites (Ser523 and Tyr570) in JAK2.

Products for  JAK

  1. Cat.No. 产品名称 Information
  2. GC13433 AZ 960

    5-氟-2-[[(1S)-1-(4-氟苯基)乙基]氨基]-6-[(5-甲基-1H-吡唑-3-基)氨基]-3-吡啶腈,AZ-960,AZ960

    A JAK2 inhibitor
  3. GC17050 CYT387

    莫洛替尼,Cyt-387,MOMELOTINIB,CYT 387,CYT 11387

    A potent inhibitor of JAK1 and JAK2
  4. GC14844 Baricitinib (LY3009104, INCB028050)

    巴瑞替尼; LY3009104; INCB028050

    Baricitinib (LY3009104, INCB028050)是一种高效口服JAK1/JAK2抑制剂,对JAK1和JAK2的IC50值分别为5.9nM和5.7nM。
  5. GC15980 WP1066

    (2E)-3-(6-溴-2-吡啶基)-2-氰基-N-[(1S)-1-苯基乙基]-2-丙烯酰胺

    WP1066是一种STAT3(信号转导和转录激活因子3)可逆的竞争性抑制剂,针对STAT3 Tyr705位点磷酸化的抑制IC50约为2.5μM,通常用于恶性肿瘤及炎症相关疾病的研究。
  6. GC16828 Tofacitinib (CP-690550,Tasocitinib)

    托法替尼; Tasocitinib; CP-690550

    Tofacitinib (CP-690550,Tasocitinib)是一种Janus激酶(JAK)抑制剂,用于治疗类风湿关节炎、银屑病关节炎、强直性脊柱炎、多关节病程青少年特发性关节炎和溃疡性结肠炎。
  7. GC12504 AZD1480

    5-氯-N2-[(1S)-1-(5-氟-2-嘧啶基)乙基]-N4-(5-甲基-1H-吡唑-3-基)-2,4-嘧啶二胺,AZD 1480

    AZD1480是一种JAK抑制剂(JAK1:IC50 = 1.3nM;JAK2:IC50 = 0.4nM)
  8. GC14324 TG101348 (SAR302503)

    N-(1,1-二甲基乙基)-3-[[5-甲基-2-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-4-嘧啶基]氨基]苯磺酰胺,Tg-101348,SAR-302503

    TG101348 (SAR302503)是一种选择性小分子JAK2抑制剂,IC50值为3nM。
  9. GC17586 Tofacitinib (CP-690550) Citrate

    枸橼酸托法替尼; Tasocitinib citrate; CP-690550 citrate

    A pan-JAK inhibitor
  10. GC14191 Ruxolitinib (INCB18424)

    芦可替尼; INCB18424

    Ruxolitinib (INCB18424)作为一种抑制剂,能够抑制Janus相关激酶(JAKs)JAK1和JAK2, IC50 分别为 3.3 nM 和 2.8 nM,Ruxolitinib介导对造血和免疫功能重要的若干细胞因子和生长因子信号。

  11. GN10442 Curculigoside

    仙茅苷

    仙茅苷是 C. 中的主要皂苷。
  12. GN10627 Atractylenolide I

    白术内酯 I

    A sesquiterpene with diverse biological activities
  13. GN10584 Ginsenoside Rk1

    人参皂苷

    人参皂甙 Rk1 是通过在高温下加工人参植物(主要是 Sung Ginseng,SG)而产生的独特成分 。

Items 151 to 162 of 162 total

per page
  1. 1
  2. 2
  3. 3
  4. 4

Set Descending Direction